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Abstract
Background: Hemodialysis (HD) treatment for end-stage renal disease (ESRD) (HD+ESRD) may increase the risk of
intracranial hemorrhage (ICH) after a head injury (HI) for which heparin is used. However, the results of noncontrast
head computed tomography (CT) in such patients are not always clear. We aimed to evaluate the effect of HD on
the risk of ICH in ESRD patients and in controls without ESRD with HD (HD−ESRD), and to determine whether to
lower the threshold of head CT in HD+ESRD patients after HI.
Methods: In this nationwide population-based study using Taiwan’s National Health Insurance Research Database,
we enrolled 6938 HD+ESRD HI patients for the case group and 13,876 randomly selected HD−ESRD HI patients for the
control group. Measures of the post-HI association between HD+ESRD and ICH determined using conditional logistic
regression.
Results: Five hundred sixty-eight (2.74 %) patients had post-HI ICH: 185 in the HD+ESRD group (2.67 % of cases) and
383 were from the HD−ESRD group (2.76 % of controls). Conditional logistic regression analysis revealed that after
adjusting for age, gender, diabetes, hypertension, congestive heart failure, stroke, cancer, and liver disease, HD+ESRD
patients had no higher odds of ICH (adjusted odds ratio [AOR]: 0.91; 95 % confidence interval [CI]: 0.75–1.11) than did
HD−ESRD patients. In the subgroup analysis of immediate ICH, HD+ESRD patients had lower odds than did HD−ESRD
patients (AOR: 0.73; 95 % CI: 0.56–0.94).
Conclusions: HD+ESRD did not increase the post-HI risk of ICH. Therefore, it may not be necessary to lower the
threshold of head CT in HD+ESRD patients.
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Introduction
The population of patients with end-stage renal disease
(ESRD) who require dialysis is progressively growing,
and the mortality rate of this group is much higher than
that of the general population in the U.S.[1]. In 2009,
116,395 patients started therapy for ESRD, and the
prevalent population reached 571,414, including 398,861
dialysis patients [1]. The incident rate increased 1.1 %, to
355.4 per million, and total expenditures reached $42.5
billion [1]. In Taiwan, the number of ESRD patients who
require hemodialysis (HD) has also increased consider-
ably over the past two decades [2]. Taiwan has had the
greatest incidence of ESRD since 2000, according to an
international comparison based on data from the U.S.
Renal Data System [3].
Head injury (HI) often results in lifelong physical, cog-
nitive, behavioral, and social dysfunction for patients
who, in turn, may place major social and financial bur-
dens on their families and society [4, 5]. It is estimated
that, in the U.S., around 5.3 million people are living
with a HI-related disability [6], and in the E.U., approxi-
mately 7.7 million people who have experienced HI have
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disabilities [7]. There has been a shift toward older
patients with HI for whom falls are the primary cause of
HI among the elderly, resulting in more contusion injur-
ies [8]. The high incidence of comorbidities and the
frequent use of platelet aggregation inhibitors and oral
anticoagulants among older patients have a negative in-
fluence on outcome after HI [8].
The widespread availability of head computed tomog-
raphy (CT) has greatly helped physicians to better man-
age patients with HI [9]. Head CT is considered
mandatory for all HI patients with an initial or persistent
altered level of consciousness [9]. The role of the head
CT in a patient with mild HI and a normal level of con-
sciousness remains controversial [9]. In the New Orleans
[10] and Canadian CT Clinical Decision Rules [11], head
CT is indicated in patients with “known coagulopathy”
who are on chronic anticoagulant therapy or are alcohol
dependent; however, coagulopathy is potentially a signifi-
cant risk factor for traumatic intracranial hemorrhage
(ICH). HD and continuous renal replacement therapies
require extracorporeal blood flow. Some type of anti-
coagulant, usually heparin or warfarin, is required to
prevent thrombosis. However, there is no agreement
about how heparin affects with HD+ESRD patients with
HI. We analyzed a population-based cohort taken from
Taiwan’s National Health Insurance Research Database
(NHIRD) to determine the risk of ICH after HI in HD
+ESRD patients. We hypothesized that HD+ESRD increase
the risk for ICH in patients with HI.
Methods
Data sources
Taiwan’s universal National Health Insurance (NHI)
Program covers nearly 100 % of the country’s population
[12]. The National Health Insurance Research Database
(NHIRD), one of the largest and most complete
population-based healthcare datasets in the world, contains
encrypted patient identification numbers, ICD-9-CM codes
for basic sociodemographic information, procedures, diag-
noses, prescribed drugs, and dates of discharge and admis-
sion [13]. All the expenses of ESRD, HD, HI, and ICH are
covered by NHI.
Ethics statement
This study was conducted according to the Declaration of
Helsinki. The Institutional Review Board at Chi-Mei Med-
ical Center approved this study (IRB approved number
10404-E2) and waived the need for informed consents
from the patients because the data in this study consists of
unidentifiable, national, secondary data released to the
public for research. The rights and welfare of the patients
are not affected adversely by the waiver.
Selection of cases and controls
This longitudinal study selected, for the case group, all
ESRD patients on maintenance HD (HD+ESRD) with
new-onset HI (ICD-9 codes: 850 [Concussion], 852
[Subarachnoid, subdural and extradural haemorrhage,
following injury], 853 [Other and unspecified intracra-
nial hemorrhage following injury], 854 [Intracranial in-
jury of other and unspecified nature], 959.0 [Injury to
head, face and neck], 959.01 [Head injury, unspecified],
959.09 [Injury of face and neck]) between 2002 and 2008
(Fig. 1). Their ESRD diagnoses were confirmed if the
database indicated that they had a catastrophic illness
certificate with the ICD-9 code number 585 for chronic
kidney disease.
We also selected two matched controls per case from
the Longitudinal Health Insurance Database 2000
(LHID2000), a data subset of the NHIRD that contains
claims data for one million beneficiaries randomly selected
from the full NHIRD in 2000. There are no significant
differences in age, gender, and healthcare costs be-
tween the LHID2000 sample group and all NHI enrol-
lees (Fig. 1). The definition of controls was patients
who did not have ESRD with HD (HD-ESRD). Controls
(HD−ESRD) were matched with cases by age, gender,
and index year. Patients diagnosed with ESRD were
excluded. As with the cases, we assigned the first use
of medical care during the index year as the index date
for controls.
We linked to the diagnostic codes through the ambu-
latory and inpatient care claims databases of the NHI.
Baseline comorbidities affecting ICH that may have
presented before the index date were diabetes mellitus
(DM) (ICD-9 code 250), hypertension (HTN) (ICD-9
codes 401–405), congestive heart failure (CHF) (ICD-9
codes 428), stroke (ICD-9 codes 430–438), cancer
(ICD-9 codes 140–208), and liver disease (ICD-9 codes
571.2, 571.4, 571.5, 571.6, 456.0–456.2, 572.2–572.8).
We counted these comorbid conditions if they occurred
either in the inpatient setting or in 3 or more ambula-
tory care claims coded 12 months before the index
medical care date.
Exposure assessment
This study compared the risk of ICH between cases and
controls. In this study, we identified ICH that included
medical codes for (i) immediate ICH after HI (ICD-9
codes: 852, 853, 854); and (ii) delayed ICH within 7 days
of HI (ICD-9 codes: 852, 853, 854, 430 [Subarachnoid
hemorrhage], 431 [Intracerebral hemorrhage], 432
[Other and unspecified intracranial hemorrhage], 432.1
[Subdural hemorrhage], 432.9 [Unspecified intracranial
hemorrhage]). By definition, all patients had not been
previously diagnosed with ICH.
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Subgroup analysis
We analyzed the effect of HD+ESRD for ICH in HI pa-
tients in the subgroups based on gender, age, immediate
ICH, and delayed ICH. Elderly was defined as ≥ 65 years
old (Table 2).
Statistical analysis
The significance of the differences in baseline character-
istics and comorbid variables between the two groups
was evaluated using Pearson χ2 tests for categorical vari-
ables and Student’s t test for continuous variables. We
used conditional logistic regression (based on age,
gender, and index year) to examine the association of
ESRD with HD and ICH after HI after the potential con-
founders of DM, HTN, CHF, stroke, cancer, and liver
disease, measured before the index date, had been
adjusted for. SAS 9.3.1 for Windows (SAS Institute,
Cary, NC, USA) was used for all analyses. Significance
was set at P < 0.05.
Results
Demographic data of total patients with HI
Between 2002 and 2008, we recruited 6938 patients with
HD+ESRD and 13,876 age- and gender-matched controls,
after ineligible patients had been excluded (Fig. 1;
Table 1). The mean ages in the case and control groups
on the HI date were identical: 65.52 ± 12.96 years old
(Table 1). All patients were subclassified into 2 age
groups: 0–64 years old and ≥ 65 years old (Table 1).
Pearson χ2 tests revealed a significant difference between
the distribution of the comorbidities of DM, HTN, CHF,
Fig. 1 Flow chart of the study. HI, head injury; ESRD, end-stage renal disease; LHID2000, Longitudinal Health Insurance Database 2000; HD,
hemodialysis; ICH, intracranial hemorrhage
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stroke, cancer, and liver disease in cases and controls
after matching (Table 1).
Risk of ICH after HI
Of the 6938 HD+ESRD patients, 185 (2.67 %) had ICH
after HI during the follow-up period (Table 2). In the
HD−ESRD group, 383 of 13,876 patients (2.76 %) had ICH
after HI during the follow-up period (Table 2). The
crude OR was 0.97 (95 % CI: 0.81–1.15). After adjusting
for patient age, gender, and comorbidities, HD+ESRD was
not associated with an increased risk of ICH after HI
compared with the control group (AOR: 0.91; 95 % CI:
0.75–1.11) (Table 2).
Subgroup analysis
When patients were categorized by gender and age, the
difference in the risk of ICH between 2 subgroups was
not significant (Table 2). In an analysis of immediate and
delayed ICH, HD+ESRD patients had a lower risk than
did HD−ESRD patients (AOR: 0.73; 95 % CI: 0.56–0.94),
especially in the females (AOR: 0.61; 95 % CI: 0.43–0.87)
and those ≥ 65 years old (AOR: 0.70; 95 % CI: 0.50–0.97)
(Table 3). In the delayed ICH analysis, there was no dif-
ference between HD+ESRD and HD−ESRD patients
(Table 4).
Discussion
Using a nationwide population-based study design with
a large sample, we found that ESRD with HD did not
increase the risk of ICH after HI, regardless of age or
gender. Moreover, HD+ESRD patients had a lower risk
of immediate ICH. To the best of our knowledge, this
is the first study to report the associations between
HD+ESRD and the risk of ICH after HI. Our findings sug-
gest that it may not be necessary for physicians to lower
Table 1 Demographic characteristics of patients with head
injury
Characteristic Cases (HD+ESRD) Controls (HD−ESRD) P
Number of patients 6938 13,876
Age (years) 65.52 ± 12.96 65.52 ± 12.96 0.9978
0–64 3004 (43.30) 6008 (43.30) >0.999
≥ 65 3934 (56.70) 7868 (56.70)
Gender
Male 3040 (43.82) 6080 (43.82) > 0.999
Female 3898 (56.18) 7796 (56.18)
Comorbidities
DM 3009 (43.37) 2538 (18.29) < 0.0001
HTN 4056 (58.46) 5051 (36.40) < 0.0001
CHF 1035 (14.92) 485 (3.50) < 0.0001
Stroke 1276 (18.39) 1743 (12.56) < 0.0001
Cancer 516 (7.44) 540 (3.89) < 0.0001
Liver disease 727 (10.48) 939 (6.77) < 0.0001
Data are presented as n (%) or means ± standard deviation. ESRD end-stage
renal disease, HD hemodialysis, DM diabetes mellitus, HTN hypertension, CHF
congestive heart failure
Table 2 Comparison of the risk of intracranial hemorrhage after head injury between Case (HD+ESRD) and Control (HD−ESRD) groups
Outcome Cases Controls Crude OR P AOR P
Overall
Yes, n (%) 185 (2.67) 383 (2.76) 0.97 (0.81–1.15) 0.6961 0.90 (0.74–1.10) 0.3012
No, n (%) 6753 (97.33) 13,493 (97.24) 1.00 1.00
Gender
Male
Yes, n (%) 93 (3.06) 170 (2.80) 1.10 (0.85–1.42) 0.4788 1.03 (0.76–1.40) 0.8448
No, n (%) 2947 (96.94) 5910 (97.20) 1.00 1.00
Female
Yes, n (%) 92 (2.36) 213 (2.73) 0.86 (0.67–1.10) 0.2361 0.78 (0.59–1.03) 0.0826
No, n (%) 3806 (97.64) 7583 (97.27) 1.00 1.00
Age (years)
0 < 65
Yes, n (%) 84 (2.80) 157 (2.61) 1.07 (0.82–1.40) 0.6112 1.01 (0.72–1.42) 0.9587
No, n (%) 2920 (97.20) 5851 (97.39) 1.00 1.00
≥ 65
Yes, n (%) 101 (2.57) 226 (2.87) 0.89 (0.70–1.13) 0.3430 0.83 (0.64–1.08) 0.1596
No, n (%) 3833 (97.43) 7642 (97.13) 1.00 1.00
Data are presented as n (%). Conditional logistical regression was used. Adjusted by DM, HTN, CHF, stroke, cancer, and liver disease. ESRD end-stage renal disease,
HD hemodialysis, OR odds ratio, AOR adjusted odds ratio
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Table 3 Comparison of the risk of immediate intracranial hemorrhage after head injury between Case (HD+ESRD) and Control
(HD−ESRD) groups
Outcome Case Control Crude OR P AOR P
Overall
Yes, n (%) 107 (1.54) 275 (1.98) 0.78 (0.62–0.97) 0.0263 0.73 (0.56–0.94) 0.0166
No, n (%) 6831 (98.46) 13,601 (98.02) 1.00 1.00
Gender
Male
Yes, n (%) 56 (1.84) 118 (1.94) 0.95 (0.69–1.31) 0.7449 0.85 (0.57–1.28) 0.4420
No, n (%) 2984 (98.16) 5962 (98.06) 1.00 1.00
Female
Yes, n (%) 51 (1.31) 157 (2.01) 0.65 (0.47–0.89) 0.0070 0.61 (0.43–0.87) 0.0064
No, n (%) 3847 (98.69) 7639 (97.99) 1.00 1.00
Age (years)
0 < 65
Yes, n (%) 46 (1.53) 116 (1.93) 0.79 (0.56–1.11) 0.1780 0.79 (0.51–1.22) 0.2860
No, n (%) 2958 (98.47) 5892 (98.07) 1.00 1.00
≥ 65
Yes, n (%) 61 (1.55) 159 (2.02) 0.77 (0.57–1.03) 0.0766 0.70 (0.50–0.97) 0.0314
No, n (%) 3873 (98.45) 7709 (97.98) 1.00 1.00
Data are presented as n (%). Conditional logistical regression was used. Adjusted by DM, HTN, CHF, stroke, cancer, and liver disease. ESRD end-stage renal disease,
HD hemodialysis, OR odds ratio, AOR adjusted odds ratio
Table 4 Comparison of the risk of delayed intracranial hemorrhage after head injury between the Case (HD+ESRD) and Control
(HD−ESRD) groups
Outcome Case Control Crude OR P AOR P
Overall
Yes, n (%) 78 (1.12) 108 (0.78) 1.46 (1.09–1.96) 0.0124 1.35 (0.97–1.88) 0.0737
No, n (%) 6860 (98.88) 13,768 (99.22) 1.00 1.00
Gender
Male
Yes, n (%) 37 (1.22) 52 (0.86) 1.43 (0.94–2.19) 0.0990 1.41 (0.86–2.29) 0.1706
No, n (%) 3003 (98.78) 6028 (99.14) 1.00 1.00
Female
Yes, n (%) 41 (1.05) 56 (0.72) 1.48 (0.98–2.24) 0.0595 1.28 (0.81–2.02) 0.2950
No, n (%) 3857 (98.95) 7740 (99.28) 1.00 1.00
Age (years)
0 < 65
Yes, n (%) 38 (1.26) 41 (0.68) 1.89 (1.21–2.96) 0.0055 1.46 (0.78–2.73) 0.2353
No, n (%) 2966 (98.74) 5967 (99.32) 1.00 1.00
≥ 65
Yes, n (%) 40 (1.02) 67 (0.85) 1.20 (0.81–1.78) 0.3703 1.16 (0.77–1.76) 0.4829
No, n (%) 3894 (99.98) 7801 (99.15) 1.00 1.00
Data are presented as n (%). Conditional logistical regression was used. Adjusted by DM, HTN, CHF, stroke, cancer, and liver disease. ESRD end-stage renal disease,
HD hemodialysis, OR odds ratio, AOR adjusted odds ratio
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the threshold of head CT in HD+ESRD patients after HI.
In the HD+ESRD elderly, a subgroup more sensitive to
ICH, the criteria for head CT need not be different from
those of the general population. This evidence should be
valuable for establishing future guidelines for managing
HI and may reduce medical costs by reducing the num-
ber of head CTs done, especially in the elderly.
Heparin has a short half-life of about one hour [14],
which might be the most important reason that the risk
for ICH does not rise after HI. One meta-analysis [15]
suggests that using heparin use during dialysis does not
significantly increase the risk of bleeding. Another study
[16] reported that access-related bleeding was the most
common in patients on HD [16]. Major bleeding related
to heparin such as brain, gastrointestinal tract, and peri-
cardium are uncommon, except for patient-specific rea-
sons [16]. Heparin is commonly administered as a bolus
injection before dialysis begins, and is then continuously
infused during the dialysis treatment [17]. Before the
end of dialysis, heparin infusions are typically stopped
for approximately 30 min [16]. This procedure permits
prompt hemostasis after the access needles have been
removed [16]. It also protects patients from being ex-
posed to a bleeding risk after HD.
There are no published studies about ICH after HI in
HD+ESRD patients. However, the published studies
about the risk of non-traumatic ICH in HD patients
have controversial results. In one Japanese study [18],
HTN and the amount of HD prescribed were the risk
factors, but anticoagulation with heparin was not. A
study based on the US Renal Data System [19] showed
that the occurrence rate of non-traumatic subdural
hematoma in long-term HD patients is 10 times higher
than that of the general population. The author con-
cluded that it may be related to a greater use of antico-
agulants in long-term HD patients; however, the study
focused only on subdural hematoma and did not in-
clude patients with other types of ICH, such as sub-
arachnoid, intracerebral, and epidural hemorrhages. In
addition, it enrolled patients with traumatic and with
non-traumatic ICH, which is different from our goal for
traumatic ICH.
Bleeding is also a great concern in HD patients who
need surgery. However, studies on this topic are also in-
consistent. In two studies [20, 21], there was no greater
incidence of bleeding in dialysis patients undergoing a
vitrectomy for diabetic retinopathy. In a study about
non-cardiac surgeries [22], HD patients had a risk for
postoperative bleeding 1.4 times higher than that of
non-HD patients. Although there are no randomized
prospective studies, it is unlikely that individuals whose
ESRD is well managed with HD would have a greater
risk for clinically significant bleeding, even from multiple
dental extractions.
Our study showed that the incidence of ICH in elderly
HD+ESRD patients was no higher than in elderly HD
−ESRD patients. Age is a risk factor for ICH, even in mild
HI. In the Canadian CT Head Rule [11] and New
Orleans Criteria [10], the elderly have a greater risk of
clinically significant lesions that require acute neurosur-
gical intervention or prolonged inpatient observation
[23, 24]. Early CT scanning, where it is available, is
strongly indicated [23, 24].
Our study showed that HD+ESRD patients had more
comorbidities but a lower risk of immediate ICH after
HI than did HD-ESRD patients. Immediate ICH after
HI always comes from a more severe trauma mechan-
ism [25, 26]. HD+ESRD patients are more sedentary
than HD-ESRD patients due to lowered hemoglobin level,
lower extremity muscle strength, and poor physical func-
tioning [27]. Therefore, more sedentary life style may
contribute to a lower risk of immediate ICH after HI
in HD+ESRD patients.
There are several limitations to this study. First, there
was no information on the severity of ICH or HI; there-
fore, we were unable evaluate the severity association
between them. Second, some important drugs such as
warfarin and aspirin were not investigated; therefore, we
were unable to adjust for these variables as contributing
factors in this study. Third, some HD+ESRD patients used
heparin-free protocol during HD. However, the propor-
tion was small [28] and might not affect the final result
of this large-scale study. Finally, despite our database be-
ing national, our findings may not be generalizable to
other nations.
Conclusions
This is the first nationwide population-based study to
clarify that HD+ESRD patients have no greater risk of
ICH after HI than do HD−ESRD patients, regardless of
age. In the immediate ICH analysis, HD+ESRD patients
showed a lower risk than did HD−ESRD patients. There-
fore, it may not necessary for physicians to lower the
threshold of head CT in HD+ESRD patients after HI.
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